Business

Around the Region

Pre-transplant heart device is OK’d

Advertisement

Federal regulators on Tuesday approved for sale in the United States a mechanical pump built by a Framingham company as a “bridge therapy” to support heart function and blood flow in patients with end-stage heart failure who are awaiting a heart transplant.

The device cleared by the Food and Drug Administration, called the HeartWare Ventricular Assist System, was developed by Heart Ware International Inc. Designed for use inside or outside the hospital, it includes an implantable pump with an external driver and power source. The device has been on the market in Europe­ since 2009 and in ­Australia since last year.

“For patients awaiting a ­donor heart, the HeartWare System provides a new ­treatment option,” said Christy Foreman, director of the Office of Device Evaluation in the FDA’s Center for Devices and Radiological Health.

Robert Weisman can be reached at weisman@globe.com.
Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.
You're reading  1 of 5 free articles.
Get UNLIMITED access for only 99¢ per week Subscribe Now >
You're reading1 of 5 free articles.Keep scrolling to see more articles recomended for you Subscribe now
We hope you've enjoyed your 5 free articles.
Continue reading by subscribing to Globe.com for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com